CELL EXPANSION MARKET ANALYSIS

Cell Expansion Market, by Product (Consumables, (Media, Others), Instruments (Automated Cell, Expansion Systems, Cell Counters, Centrifuges, Bioreactors, Others), Accessories), by Cell Type (Mammalian Cells, (Human Cells, Stem Cells, Adult Stem Cells, Induced Pluripotent Stem Cells, Embryonic Stem Cells), Differentiated Cells, Animal Cells), Microbial Cells, Others (Plant-derived Cells)), by Application (Biopharmaceuticals, Tissue Culture & Engineering, Vaccine Production, Drug Development, Cancer Research, Stem Cell Research, Other Applications), by End User (Biotechnology Companies, Biopharmaceutical Companies, Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) Size, Share, Outlook, and Opportunity Analysis, 2024 - 2031

Published In : Mar 2024
Code : CMI1293
Pages :402
Formats :
Excel and PDF
Industry : Biotechnology

Market Challenges And Opportunities

Global Cell Expansion Market – Restraints

Animal and human cells are also utilized to evaluate medicines for in vivo toxicity and pharmacokinetics in animals and humans. Furthermore, stem cell research uses human embryos for clinical purposes, which frequently results in the killing of human embryos. Stringent restrictions have been created by ethical authorities such as The Human Tissue Authority (HTA), the Human Fertilization and Embryology Authority (HFEA), etc. in numerous nations across the world to supervise these operations. For instance, prohibitions under the 1990 Act on Human Embryo Research by the Human Fertilization and Embryology Authority includes, keeping or using an embryo after the appearance of the primitive streak, or after 14 days whichever is the earlier, placing an embryo in a non-human animal, placing non-human gametes or embryos in a woman, replacing a nucleus of a cell of an embryo with a nucleus taken from the cell of another person, another embryo, or a subsequent development of an embryo, altering the genetic structure of any cell while it forms part of an embryo.

Increasing acquisition by market players of cell and gene therapy manufacturing facilities
Restrictions created by ethical authorities for the use of human embryos